Sort   by:  
 Page size 
UnknownB.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination.
Not available
S-EPMC8487035 | biostudies-literature
UnknownThe Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
Not available
S-EPMC8702401 | biostudies-literature
UnknownSARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
Not available
S-EPMC8238662 | biostudies-literature
UnknownHost Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
Not available
S-EPMC9698971 | biostudies-literature
UnknownSARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies.
Not available
S-EPMC9072809 | biostudies-literature
UnknownACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization.
Not available
S-EPMC11559990 | biostudies-literature
UnknownSARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Not available
S-EPMC11317634 | biostudies-literature
UnknownHumoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
Not available
S-EPMC8384414 | biostudies-literature
Sort   by:  
 Page size